Peripheral Extracorporeal Membrane Oxygenation System as Salvage Treatment of Patients With Refractory Cardiogenic Shock: Preliminary Outcome Evaluation

Artificial Organs

Volumn 36, Issue 3, 2012, Pages

  Loforte, Antonio ^a   Montalto, Andrea ^a   Ranocchi, Federico ^a   Della Monica, Paola Lilla ^a   Casali, Giovanni ^a   Lappa, Angela ^a   Menichetti, Antonio ^a   Contento, Carlo ^a   Musumeci, Francesco ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Cardiogenic shock; Extracorporeal membrane oxygenation; Mechanical circulatory support

Indexed keywords

CARDIOLOGY; LEFT VENTRICULAR ASSIST DEVICES; OXYGENATION; PLATELETS; REFRACTORY MATERIALS; REGRESSION ANALYSIS; RESUSCITATION;

CARDIOGENIC SHOCKS; CONFIDENCE INTERVAL; CREATINE KINASE; EXTRACORPOREAL MEMBRANE OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; ODD RATIOS; OXYGENATION SYSTEMS; RED BLOOD CELL; RELATIVE INDICES; SALVAGE TREATMENT;

RESPIRATORY THERAPY;

ACETYLSALICYLIC ACID; CREATINE KINASE MB; FONDAPARINUX; FRESH FROZEN PLASMA; HEPARIN; LACTIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CLINICAL EVALUATION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; FEMALE; GRAFT FAILURE; HEART ASSIST DEVICE; HEART HEMODYNAMICS; HUMAN; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; SALVAGE THERAPY; SURVIVOR; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84858004670     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01423.x     Document Type: Article

References (34)

1. Bartlett RH, Gazzaniga AB, Jefferies MR, etal. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infants. ASAIO Trans 1976;22:80-93.
2. Extracorporeal Life Support Organization. ELSO Registry. Available at: Accessed July 2011.
3. Kolobow T, Bowman RL. Construction and elimination of an alveolar membrane artificial heart-lung. ASAIO Trans 1963;9:238.
4. Bramson ML, Osborn JJ, Main FB. A new disposable membrane oxygenation with integral heat exchanger. J Thorac Cardiovasc Surg 1965;50:391.
5. Loforte A, Montalto A, Ranocchi F, etal. Levitronix CentriMag third-generation magnetically levitated continuous flow pump as bridge to solution. ASAIO J 2011;57:247-53.
6. Nolan JP, Morley PT, Vanden Hoek TL, etal. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation 2003;108:118-21.
7. Zhang R, Kofidis T, Hiroyouki K, etal. Creatine kinase isoenzyme MB relative index as predictor of mortality on extracorporeal membrane oxygenator support for postcardiotomy cardiogenic shock in adult patients. Eur J Cardiothorac Surg 2006;30:617-20.
8. Hausmann H, Potapov EV, Koster A, etal. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation 2002;106(Suppl. 1):I203-6.
9. Pappalardo F, Scandroglio A, Maj G, Zangrillo A, D'Angelo A. Preliminary experience with fondaparinux. Treatment of heparin-induced thrombocytopenia after cardiac surgery. J Thorac Cardiovasc Surg 2010;139:790-2.
10. Chen JS, Ko WJ, Yu H, etal. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med 2006;34:950-7.
11. Doll N, Kiaii B, Borger M, etal. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004;77:151-7.
12. Hoefer D, Ruttmann E, Poelzl G, etal. Outcome evaluation of the bridge to bridge concept in patients with cardiogenic shock. Ann Thorac Surg 2006;82:28-34.
13. Combes A, Leprince P, Luyt C, etal. Outcomes and long-term quality of life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008;36:1404-11.
14. Agati S, Ciccarello G, Fachile N, etal. DIDECMO: a new polymethylpentene oxygenator for pediatric extracorporeal membrane oxygenation. ASAIO J 2006;52:509-12.
15. Horton S, Thuys C, Bennet M, etal. Experience with the Jostra Rotaflow and Quadrox D oxygenator for ECMO. Perfusion 2004;19:17-23.
16. Peek GJ, Killer HM, Reeves R, etal. Early experience with a polymethylpentene oxygenator for adult extracorporeal life support. ASAIO J 2002;48:480-2.
17. Toomasian JM, Schreiner RJ, Meyer DE, etal. A polymethylpentene fiber gas exchange for long-term extracorporeal life support. ASAIO J 2005;51:390-7.
18. Saito S, Nakatani T, Kobayashi J, etal. Is extracorporeal life support contraindicated in elderly patients? Ann Thorac Surg 2007;83:140-5.
19. Smedira N, Moazami N, Golding CM, etal. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001;122:92-102.
20. Sung K, Lee YT, Park PW, etal. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support. Ann Thorac Surg 2006;82:651-6.
21. Zimpefer D, Heinisch B, Czerny M, etal. Late vascular complications after extracorporeal membrane oxygenation support. Ann Thorac Surg 2006;81:892-5.
22. Ko W, Lin C, Chen RJ, etal. Extracorporeal membrane oxygenation for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002;73:538-45.
23. Tayara W, Starlng RC, Yamani MH, etal. Improved survival results after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant 2006;25:504-9.
24. Formica F, Leonello A, Colagrande L, etal. Extracorporeal membrane oxygenation to support adult patients with cardiac failure: predictive factors of 30-day mortality. Interact Cardiovasc Thorac Surg 2010;10:721-6.
25. Luo XJ, Wang W, Hu SS, etal. Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients. Interact Cardiovasc Thorac Surg 2009;57:612-4.
26. Bakhtiary F, Keller A, Dogan S, etal. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experience in 45 adult patients. J Thorac Cardiovasc Surg 2008;135:382-8.
27. Liden H, Wilklund L, Haraldsson A, Berglin E, Hultman J, Dellgren J. Temporary circulatory support with extracorporeal membrane oxygenation in adult with refractory cardiogenic shock. Scand Cardiovasc J 2008;16:1-7.
28. Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry. ASAIO J 2005;51:4-10.
29. Magovern GJ, Simpson KA. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. Ann Thorac Surg 1999;68:655-61.
30. Capellan O, Hollander JE, Pollack D Jr, etal. Prospective evaluation of emergency department patients with potential coronary syndromes using initial absolute CK-MB vs. CK-MB relative index. J Emerg Med 2003;24:361-7.
31. Arpesella G, Loforte A, Mikus E, Mikus PM. Extracorporeal membrane oxygenation for primary graft failure. Transplant Proc 2008;40:3596-7.
32. Ang AL, Teo D, Lim CH, Leou KK, Tien SL, Koh MB. Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation-a single centre experience. Vox Sang 2009;96:34-43.
33. Russo CF, Cannata A, Lanfranconi M, etal. Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock. J Thorac Cardiovasc Surg 2010;140:1416-21.
34. Aziz TA, Singh G, Popjes E, etal. Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J Heart Lung Transplant 2010;29:66-71.